Tyrphostin AG 825

CAS : 149092-50-2

Ref. 3D-ZFA09250

Informations sur le produit

• Nom: Tyrphostin AG 825
• Synonymes: (2E)-3-{3-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-hydroxy-5-methoxyphenyl}-2-cyanoprop-2-enamide, (E)-3-[3-[(2-Benzothiazolythio)Methyl]-4-Hydroxy-5-Methoxyphenyl]-2-Cyano-2-Propenamide, 2-Propenamide, 3-[3-[(2-benzothiazolylthio)methyl]-4-hydroxy-5-methoxyphenyl]-2-cyano-, 3-[3-[(2-Benzothiazolylthio)methyl]-4-hydroxy-5-methoxyphenyl]-2-cyano- 2-Propenamide, 4-Hydroxy-3-Methoxy-5-(Benzothiazolylthiomethyl)Benzylidenecyanoacetamide, 5-[(Benzothiazol-2-Yl)Thiomethyl]-4-Hydroxy-3-Methoxybenzyl-Idenecyanoacetamide, 5-[(Benzthiazol-2-Yl)Thiomethyl]-4-Hydroxy-3-Methoxybenzylidenecyanoacetamide, Tyrphostin Ag 825, Tyrphostin C15

Description

Tyrphostin AG 825 is a versatile research chemical with a wide range of applications. It is a polyketide compound that has been extensively studied for its potential therapeutic effects. Tyrphostin AG 825 has shown promising results in inhibiting the activity of beta-casomorphin, a peptide derived from milk protein, which may have implications for various health conditions.

In addition to its role in studying beta-casomorphin, Tyrphostin AG 825 has also been used in research related to cephalosporins and fluoroquinolones, two classes of antibiotics. It has been found to enhance the antibacterial activity of these drugs, making them more effective against certain strains of bacteria.

Furthermore, Tyrphostin AG 825 exhibits properties that make it useful in other areas of research as well. It has been studied for its potential anti-glycation effects, which could have implications for managing conditions related to advanced glycation end products (AGE

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 397.47 g/mol
• Formule: C₁₉H₁₅N₃O₃S₂
• Degré de pureté: Min. 95%